Clinical Trials on IgG4 Related Disease

Total 386969 results

National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase IV - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VI - 7

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Opioid-Related Disorders

United States
University Hospital, Bordeaux

Completed

Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease (CALMET)

Metabolic Diseases | Liver Diseases, Alcoholic

France
Indiana University
National Institute on Drug Abuse (NIDA)

Recruiting

Maternal Brain Imaging in Opioid Use Disorder

Substance-Related Disorders | Pregnancy Related | Narcotic-Related Disorders | Substance Use | Opioid Use Disorder | Buprenorphine Dependence

United States
Indivior Inc.

Completed

Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) (OPUS R)

Naloxone | Drug Abuse | Opiate Dependence | Buprenorphine | Opiate-related Disorders
National Institute on Drug Abuse (NIDA)

Completed

Effect of Clonidine on Responses to Imagery Scripts

Cocaine Abuse | Heroin Abuse

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases

Drug Abuse | Opioid-related Disorders | Narcotic Abuse | Opioid Addiction
Yih-Ing Hser
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Not yet recruiting

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) (RXR)

Substance-Related Disorders | Opioid-Related Disorders | Narcotic-Related Disorders

United States
West Virginia University
National Institute on Drug Abuse (NIDA)

Recruiting

Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

Opioid-Related Disorders

United States
University of Pennsylvania
Yale University

Recruiting

Tau PET Imaging in Opioid Use Disorder

Opioid-Related Disorders

United States
Geisinger Clinic

Completed

Evaluation of a Medication Disposal Program in Primary Care

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 3

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Feasibility Study of Take-Home LAAM Medication - 3

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Improving Learning-based Treatment of Cocaine Dependence With Medication

COCAINE-RELATED DISORDERS

United States
National Institute on Drug Abuse (NIDA)

Completed

Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

Opioid-Related Disorders

United States
University of Pennsylvania

Completed

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Opioid-Related Disorders

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Naltrexone-P1 A-Cocaine

Cocaine-related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Opioid Agonist and Antagonist Effects on Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 3 - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Assessment of Tramadol as a Treatment for Opioid Addiction

Opioid-Related Disorders

United States
Denver Health and Hospital Authority
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

Alcohol Related Disorders

United States, Canada
US Department of Veterans Affairs

Completed

Effect Of Case Management Following Discharge From Methadone Treatment

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
West Virginia University

Recruiting

An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder

Substance-Related Disorders | Chemically-Induced Disorders | Opioid-use Disorder | Mental Disorder

United States
Johns Hopkins Bloomberg School of Public Health

Completed

Strategies to Reduce Addiction Stigma Among Health Professionals

Opioid Use Disorder | Substance Use Disorders | Stigma, Social

United States
Centre Hospitalier St Anne

Terminated

Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response (TCC-MBCT)

Alcohol Dependence | Bipolar Disorder | Anxious Disorder

France
Vanderbilt University Medical Center
University of Toronto; University of Ottawa

Recruiting

NATIENS: Optimal Management and Mechanisms of SJS/TEN (NATIENS)

Stevens-Johnson Syndrome | Toxic Epidermal Necrolyses

United States
Sheba Medical Center

Unknown

Pascal Pascal Dynamic Contour Tonometer (DCT) Intraocular Pressure and Ocular Pulse Amplitude in Patients With Thyroid Related Orbitopathy: A Comparison to Goldmann Tonometer and to Muscles Characteristics on CT Scan

Thyroid Related Orbitopathy

Israel
University Hospital, Angers

Completed

Prevalence of Chronic Pain and Its Risk Factors After a Surgical Intensive Care Unit Stay. Prospective Observational Cohort (DOUCREA)

Opioid-Related Disorders | Critically Ill | Pain, Chronic

France
Pontificia Universidad Catolica de Chile
Servicio Nacional para la Prevención y Rehabilitación del Consumo de Drogas...

Completed

"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."

Substance-Related Disorders | Alcohol-Related Disorders | Substance Abuse

Chile
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Recruiting

A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes (2IQP)

Type 2 Diabetes Treated With Insulin

United States, Canada
Pacific Diabetes Technologies
Oregon Health and Science University

Not yet recruiting

Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes

Type 2 Diabetes Treated With Insulin
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Completed

Control-IQ Technology in Individuals With Type 2 Diabetes (2IQ)

Type 2 Diabetes Treated With Insulin

United States

Clinical Trials on IgG4 Related Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations